AU652262B2 - Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions - Google Patents

Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions

Info

Publication number
AU652262B2
AU652262B2 AU19370/92A AU1937092A AU652262B2 AU 652262 B2 AU652262 B2 AU 652262B2 AU 19370/92 A AU19370/92 A AU 19370/92A AU 1937092 A AU1937092 A AU 1937092A AU 652262 B2 AU652262 B2 AU 652262B2
Authority
AU
Australia
Prior art keywords
agitation
pharmaceutical
states
treatment
nerve dysfunctions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19370/92A
Other languages
English (en)
Other versions
AU1937092A (en
Inventor
Erich F. Prof. Dr. Elstner
Elisabeth Dr. Kleber
Werner Dr.rer.nat. Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Publication of AU1937092A publication Critical patent/AU1937092A/en
Application granted granted Critical
Publication of AU652262B2 publication Critical patent/AU652262B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU19370/92A 1991-07-09 1992-07-02 Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions Ceased AU652262B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (enExample) 1991-07-09 1991-07-09
DE4122706 1991-07-09

Publications (2)

Publication Number Publication Date
AU1937092A AU1937092A (en) 1993-01-14
AU652262B2 true AU652262B2 (en) 1994-08-18

Family

ID=6435763

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19370/92A Ceased AU652262B2 (en) 1991-07-09 1992-07-02 Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions

Country Status (26)

Country Link
US (1) US5308619A (enExample)
EP (1) EP0535317B1 (enExample)
JP (1) JPH085796B2 (enExample)
KR (1) KR100225010B1 (enExample)
AT (1) ATE139446T1 (enExample)
AU (1) AU652262B2 (enExample)
CA (1) CA2072950A1 (enExample)
CZ (1) CZ279915B6 (enExample)
DE (2) DE4122706C1 (enExample)
DK (1) DK0535317T3 (enExample)
EE (1) EE03169B1 (enExample)
EG (1) EG20140A (enExample)
ES (1) ES2088053T3 (enExample)
GR (1) GR3020289T3 (enExample)
HU (1) HUT61668A (enExample)
IE (1) IE74691B1 (enExample)
IL (1) IL102410A (enExample)
MD (1) MD1139G2 (enExample)
MX (1) MX9204011A (enExample)
PT (1) PT100668B (enExample)
RU (1) RU2072859C1 (enExample)
SI (1) SI9200138A (enExample)
SK (1) SK279531B6 (enExample)
UA (1) UA26971C2 (enExample)
YU (1) YU48554B (enExample)
ZA (1) ZA925059B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
ES2257042T3 (es) * 1998-03-26 2006-07-16 Phytopharm Plc Esmilagenina y anzurogenina-d para el tratamiento de enfermedad de alzheimer.
JP4615126B2 (ja) * 1999-03-11 2011-01-19 ジーケム インコーポレイテッド エタノール生産方法
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
AU2005207970B2 (en) * 2004-01-29 2011-04-28 Zeachem Inc. Recovery of organic acids
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (enExample) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Also Published As

Publication number Publication date
DE59206608D1 (de) 1996-07-25
JPH0753392A (ja) 1995-02-28
RU2072859C1 (ru) 1997-02-10
ES2088053T3 (es) 1996-08-01
SK279531B6 (sk) 1998-12-02
HU9202274D0 (en) 1992-10-28
US5308619A (en) 1994-05-03
GR3020289T3 (en) 1996-09-30
UA26971C2 (uk) 2000-02-28
CZ214392A3 (en) 1993-02-17
SI9200138A (en) 1993-03-31
EP0535317B1 (de) 1996-06-19
MX9204011A (es) 1993-07-01
SK214392A3 (en) 1994-11-09
IL102410A0 (en) 1993-01-14
IE922226A1 (en) 1993-01-13
EG20140A (en) 1997-07-31
IL102410A (en) 1998-02-22
MD1139G2 (ro) 1999-10-31
YU67492A (sr) 1996-01-09
MD1139F2 (en) 1999-01-31
PT100668B (pt) 1999-08-31
ZA925059B (en) 1993-04-28
IE74691B1 (en) 1997-07-30
PT100668A (pt) 1993-09-30
CA2072950A1 (en) 1993-01-10
JPH085796B2 (ja) 1996-01-24
HUT61668A (en) 1993-03-01
EE03169B1 (et) 1999-04-15
ATE139446T1 (de) 1996-07-15
EP0535317A1 (de) 1993-04-07
KR930001926A (ko) 1993-02-22
DE4122706C1 (enExample) 1993-03-04
AU1937092A (en) 1993-01-14
YU48554B (sh) 1998-11-05
MD950171A (en) 1996-06-28
DK0535317T3 (da) 1996-07-15
CZ279915B6 (cs) 1995-08-16
KR100225010B1 (ko) 1999-10-15

Similar Documents

Publication Publication Date Title
MX9710479A (es) Extracto de iridaceas y composiciones que la contienen.
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
SI0725779T1 (enExample)
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
AU652262B2 (en) Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
IL109982A0 (en) Pharmaceutical compositions containing isovaleramide and methods for the preparation thereof
MY117323A (en) Method of scavenging free radicals using orange extract
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
CA2013772A1 (en) N-(sulfomethyl)-n'-arylureas
AU622010B2 (en) Substituted 1,8-naphthyridines
DK0541780T3 (enExample)
JPS53111099A (en) Preparation of proteinaceous substance
GB9710636D0 (en) Novel mixture
DE3366647D1 (en) Ruscus extract, process for its preparation, and its use as a veinotonically active principle
Ilinskaya et al. Effect of exogenous amines and magnesium ions on the nitroesterase activity of microorganisms.
SU1748438A1 (ru) Композиция ингредиентов для бальзама "дальневосточный"
IE780730L (en) Veterinary composition
KR940018036A (ko) 버섯추출물을 함유한 건강식품
GEP19981157B (en) Method of treatment of ulcero-necrotic stomatitis
唐质灿 et al. A NEW SPECIES OF THE GENUS SYMPLECTOSCYPHUS (HYDROIDA) FROM THE HUANGHAI SEA
JPS53124690A (en) Preparation of ribonucleic acid product with low deoxyribo-nucleic acid content
UA11695A1 (uk) Композиція іhгредієhтів для гіркої hастойки "житомирська ювілейhа"
RU96116488A (ru) Водка "прохоровское поле"
GEP19980629B (en) “Gogi” Plant Raw Concentrale

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired